0 CHECKOUT

Research Update: Liberty Global And Related Entities Outlook Revised To Positive; 'B' Ratings Affirmed Mar 07

  • ID: 1885970
  • March 2007
  • Region: Global
  • Standard & Poors

FEATURED COMPANIES

  • Cablecom Luxembourg SCA
  • Liberty Global PLC
  • UPC Holding B.V.
  • VTR GlobalCom S.A.
  • MORE

Abstract
On March 29, 2007, Standard & Poor's Ratings Services revised its outlook on international cable TV and broadband provider Liberty Global Inc. (LGI) to positive from stable, following the publication of full-year results and the proposed increase and lengthened maturity of the group's main bank facilities at subsidiary UPC Broadband Holding B.V. (B/Positive/--). The ratings on LGI and its related entities, including the 'B' long-term corporate credit rating on LGI, were affirmed. At the same time, Standard & Poor's assigned its 'B' senior secured bank loan rating to the new L, M, and N tranches issued by UPC Broadband Holding and UPC Financing Partnership (not rated). A recovery rating of '3' was also assigned, reflecting expectations of meaningful (50%-80%) recovery...

Companies mentioned in this report are:
- Liberty Global PLC
- UPC Broadband Holding B.V.
- Cablecom Luxembourg SCA
- UPC Holding B.V.
- VTR GlobalCom S.A.

Action: Affirmed
Action: New Rating
Action: Outlook: Positive

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, READ MORE >

Note: Product cover images may vary from those shown

- Liberty Global PLC
- UPC Broadband Holding B.V.
- Cablecom Luxembourg SCA
- UPC Holding B.V.
- VTR GlobalCom S.A.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Credit Rating Report will be emailed to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.